0000899243-19-015913.txt : 20190606 0000899243-19-015913.hdr.sgml : 20190606 20190606210240 ACCESSION NUMBER: 0000899243-19-015913 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190604 FILED AS OF DATE: 20190606 DATE AS OF CHANGE: 20190606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: North Michael Paul CENTRAL INDEX KEY: 0001689925 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 19884014 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY, SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-04 0 0000896262 AMEDISYS INC AMED 0001689925 North Michael Paul 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Information Officer Common Stock 2019-06-04 4 F 0 734 113.49 D 22912 D Common Stock 2019-06-04 4 F 0 245 113.49 D 22667 D Common Stock 2019-06-04 4 F 0 489 113.49 D 22178 D Common Stock 2019-06-04 4 F 0 734 113.49 D 21444 D Common Stock 2019-06-05 4 S 0 5248 115.01 D 16196 D Common Stock 396 I Through 401(k) Plan The total amount of shares beneficially owned includes 883 shares held in an employee stock purchase plan account. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.06, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The information in this report is based on a plan statement dated as of March 31, 2019. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2019-06-06